Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Completed · Not applicable

Conditions studied: Infectious Keratitis

In brief

This study is to evaluate the efficacy of ultraviolet-A (UVA) and riboflavin application (also often referred to as corneal collagen crosslinking) as a method to enhance treatment of infectious keratitis.

Key facts

Study ID

NCT01739673

Run by

Cxlusa

People needed

13

Starts

2011-08-01

Expected to finish

2014-07-01

Last updated by the study team

2018-09-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be 18 years of age or older.
• Ability to provide written informed consent.
• Likely to complete all study visits.
• Subjects must have one eye that with a diagnosis of infectious keratitis.

You may not qualify if…

• A corneal perforation.
• Descemetocele.
• Pregnancy or breastfeeding.
• Active Herpes corneal disease.
• Patient is unwilling or unable to comply with a medication regimen and follow up appointments.

Where it is running

• Schwartz Laser Eye Center — Scottsdale, Arizona, United States
• Davidorf Eye Group — West Hills, California, United States
• Corneal Consultants of Colorado, PC — Littleton, Colorado, United States
• Center for Excellence in Eye Care — Miami, Florida, United States
• Minnesota Eye Consultants — Minneapolis, Minnesota, United States
• Ophthalmology Associates — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.